Company: INTS
Filing Date: 2025-04-25
Form Type: 8-K
Source: 0001628280-25-020057
Chunk: 2

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-04-25
Form: 8-K
Item: Item 1.01
Chunk 2
---
On April 24, 2025, the Company entered into a placement agency agreement (the “ Placement Agent Agreement”) with A. G. P./Alliance Global Partners (“ A. G. P.”) and Brookline Capital Markets, a division of Arcadia Securities,

LLC (“ Brookline”) (together, the “ Placement Agents”) pursuant to which the Company engaged A. G. P. as the lead placement agent and Brookline as the co-placement agent in connection with the Offering. The Company agreed to pay the Placement Agents a fee in cash equal to 7.0% of the gross proceeds from the sale of the Shares and Common Warrants to the Investor. The Company also agreed to reimburse the Placement Agents for all reasonable and documented travel and other out-of-pocket expenses, including the reasonable fees of legal counsel not to exceed $80,000, as well as non-accountable expenses not to exceed $25,000. The Placement Agent Agreement also contains representations, warranties, indemnification and other provisions customary for transactions of this nature.

The foregoing summaries of the Placement Agent Agreement, the Purchase Agreement, the Series B-1 Common Warrant and the Series B-2 Common Warrant do not purport to be complete and are subject to, and qualified in their entirety by, such documents attached as Exhibits 1.1, 10.1, 4.1 and 4.2, respectively, to this Current Report on Form 8-K, which are incorporated herein by reference.

This Current Report on Form 8-K does not constitute an offer to sell any securities or a solicitation of an offer to buy any securities, nor shall there be any sale of any securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

Item 8.01. Other Events